Topics :: HIV treatment
By Winnie McCroy | Thursday Jun 26, 2014
On Saturday, July 12 in California’s Griffith Park Mountains, riders will gather for the 9th Annual Saddle Up LA event, a horseback ride and country BBQ to raise funds for the AIDS service organization, The Life Group L.A.
By Anita Radix | Wednesday Jun 25, 2014
On this issue of Ask the Doc, Dr. Anita Radix addresses issues about transgender health, hormones and HIV medications. Do you need to stop taking hormones to start taking HIV meds? Find the answers here at Ask the Doc.
By EDGE | Saturday Jun 21, 2014
New York has become the newest state to legalize medical marijuana, after the Senate passed a bill on June 20 that allows cannabis to be prescribed in non-smokeable form only.
By Winnie McCroy | Monday May 12, 2014
On Wednesday, May 14, The Latino Commission on AIDS will hold Cielo Latino 14, the annual gala held at Cipriani Wall Street in New York City.
By John McDonald | Friday Apr 25, 2014
Phil Lauderhill has been HIV positive for 10 years now, but like most people cannot afford to pay for his treatment alone. He relies on the U.S. government’s Ryan White Care Act for his treatment though, like all Americans, he dreams of independence.
By Winnie McCroy | Thursday Apr 24, 2014
Singers Macklemore & Ryan Lewis are putting their fame to good use, speaking out about the 30/30 Project, which aims to create worldwide healthcare facilities in communities impacted by HIV/AIDS.
By Winnie McCroy | Thursday Apr 3, 2014
A San Diego study shows that MSM who use methamphetamine had greater T-cell activation and proliferation than nonusers, even though they had an undetectable viral load.
By Winnie McCroy | Thursday Mar 27, 2014
On March 27, Bailey House will hold their 2014 Gala & Auction at Pier 60 at Chelsea Piers in New York City. The Gala will honor the heroism of individuals and organizations that help further the Bailey House mission.
By Demetre Daskalakis | Tuesday Mar 25, 2014
Five years ago, experts would have scoffed at the idea of a cure for HIV. Today, it may be closer than ever.
By Winnie McCroy | Wednesday Mar 19, 2014
Earlier this month, at the 21st Conference on Retroviruses and Opportunistic Infections (CROI), Merck indicated plans to initiate a Phase 3 clinical trial program for doravirine in combination with ARV therapy in the second half of 2014.